NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 30, 2026 — OS Therapies advances OST-HER2 immunotherapy for osteosarcoma with FDA RMAT designation. Phase 2b results show significant survival improvement. Potential 2026 launch with commercial partner Eversana.
October 18, 2025 — EHNOTE unveils revolutionary ophthalmology cloud platform at AAO 2025, integrating EHR, ASC, PMS, PXM & RCM into one seamless system with beautiful, intuitive UI.
October 17, 2025 — HeartBeam develops portable credit-card-sized ECG device that captures 3D heart signals. Technology enables medical-grade cardiac monitoring anywhere, transforming heart disease detection and treatment.
October 17, 2025 — Izotropic's IzoView Breast CT Imaging System revolutionizes cancer screening with 360-degree 3D visualization, overcoming mammography limitations for clearer detection in dense tissue with rapid scanning.
October 17, 2025 — Ethema Health reports Q1 2025 results with 170% revenue growth to $3.5M, driven by Aria Kentucky acquisition. Company projects 40% Q2 growth and facility expansions.
October 17, 2025 — Balfour Senior Living partners with CU Anschutz to create a living lab where residents participate in aging research studies on hearing, hypertension & walking.
October 17, 2025 — Oncotelic Therapeutics develops innovative RNA cancer therapies targeting rare pediatric cancers and resistant tumors. Learn about OT-101 and their breakthrough treatments for underserved patient populations.
October 17, 2025 — Medical innovation is transforming healthcare with AI, electronic medical devices, and personalized medicine. Discover how these advancements improve patient outcomes and healthcare efficiency.
October 17, 2025 — Lorien Assisted Living wins Best Assisted Living and Best Retirement Community in Maryland for fifth consecutive year. Recognized in Daily Record's 2025 Reader Rankings with innovative memory care services.
October 17, 2025 — Romani Orthodontics in East Providence offers braces, Invisalign & orthognathic surgery. Expert care for all ages with customized treatment plans & flexible payment options.
October 17, 2025 — Cedars-Sinai develops virtual brain tumor technology that creates digital twins to predict cancer growth and treatment response, transforming brain cancer care.
October 17, 2025 — ABVC BioPharma recognized as top biotech penny stock with 103% asset growth and advancing CNS & oncology pipelines. Q3 licensing revenue reaches $1.27M with multiple Phase II trials progressing.
October 16, 2025 — HeartBeam develops portable credit-card-sized ECG device that captures 3D heart signals. Medical-grade accuracy outside hospitals could revolutionize cardiac care detection and treatment worldwide.
October 16, 2025 — American Heart Association launches CPR grant program for 40 student Heart Clubs, providing training kits & funding to create cardiac emergency response plans in schools nationwide.
October 16, 2025 — University of Calgary scientists seek 10,000 toenail samples to study radon exposure links to lung cancer risk. Groundbreaking research could improve early detection.
October 16, 2025 — NFL & American Heart Association launch 2025 CPR ambassador program with 30 players promoting lifesaving training. Learn how 90-second CPR education can double survival rates.
October 16, 2025 — NeuroOne promotes Emily Johns to Chief Administrative Officer & General Counsel. Medical tech company expands leadership to accelerate neurological treatment development for epilepsy & Parkinson's.
October 16, 2025 — Annovis Bio closes $6M direct offering to fund Alzheimer's & Parkinson's research. Late-stage clinical company advances neurodegenerative disease therapies with H.C. Wainwright placement.
October 16, 2025 — Safe and Green Holdings (NASDAQ: SGBX) expands modular construction, energy, and healthcare solutions through vertical integration. Learn about SG Echo, Olenox Energy, and SG Modular Medical deployments.
October 16, 2025 — GeoVax presents Phase 2 data showing GEO-CM04S1 COVID vaccine's strong safety profile and robust T-cell responses in immunocompromised patients at World Vaccine Congress Europe 2025.